GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Moss Genomics Inc (XCNQ:MOSS) » Definitions » Capex-to-Operating-Income

Moss Genomics (XCNQ:MOSS) Capex-to-Operating-Income : 0.00 (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Moss Genomics Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Moss Genomics's Capital Expenditure for the three months ended in Dec. 2024 was C$0.00 Mil. Its Operating Income for the three months ended in Dec. 2024 was C$-0.06 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Moss Genomics Capex-to-Operating-Income Historical Data

The historical data trend for Moss Genomics's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moss Genomics Capex-to-Operating-Income Chart

Moss Genomics Annual Data
Trend Jun22 Jun23
Capex-to-Operating-Income
- -

Moss Genomics Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Dec24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Moss Genomics's Capex-to-Operating-Income

For the Health Information Services subindustry, Moss Genomics's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moss Genomics's Capex-to-Operating-Income Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Moss Genomics's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Moss Genomics's Capex-to-Operating-Income falls into.


;
;

Moss Genomics Capex-to-Operating-Income Calculation

Moss Genomics's Capex-to-Operating-Income for the fiscal year that ended in Jun. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -0.73
=N/A

Moss Genomics's Capex-to-Operating-Income for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -0.058
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Moss Genomics  (XCNQ:MOSS) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Moss Genomics Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Moss Genomics's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Moss Genomics Business Description

Traded in Other Exchanges
Address
1030 West Georgia Street, Suite 908, Vancouver, BC, CAN, V6E 2Y3
Moss Genomics Inc is an emerging consumer genomics company that provides personalized health, anti-aging, and wellness solutions based on genomic, microbiome, and epigenome data. The company aims to eliminate barriers in healthcare by offering accessible, affordable at-home testing along with easy-to-understand actionable results.
Executives
Lucas Cahill 10% Security Holder

Moss Genomics Headlines

No Headlines